Cargando…

Salivary Alpha-Amylase Activity Levels in Catatonic Schizophrenia Decrease after Electroconvulsive Therapy

BACKGROUND: Dysfunction of the autonomic nervous system (ANS) in schizophrenia has been detected by electrophysiological methods, but the underlying mechanisms remain unknown. Several studies have suggested that measuring salivary alpha-amylase activity levels is useful for evaluating the ANS activi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kanayama, Misako, Miyaoka, Tsuyoshi, Araki, Tomoko, Hayashida, Maiko, Hashioka, Sadayuki, Horiguchi, Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2018
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5971272/ https://www.ncbi.nlm.nih.gov/pubmed/29862108 http://dx.doi.org/10.1155/2018/2623585

Ejemplares similares

Decreased Clostridium Abundance after Electroconvulsive Therapy in the Gut Microbiota of a Patient with Schizophrenia
por: Kanayama, Misako, et al.
Publicado: (2019)

Electroconvulsive shock attenuated microgliosis and astrogliosis in the hippocampus and ameliorated schizophrenia-like behavior of Gunn rat
por: Limoa, Erlyn, et al.
Publicado: (2016)

PM375. Electroconvulsive shock ameliorated the schizophrenia-like behavior and attenuated the glial activation in the hippocampus of Gunn Rat
por: Abdul Aziz, Erlyn Limoa Ilhamuddin, et al.
Publicado: (2016)

PM363. The effect of Ketamine: Gunn rat as a Schizophrenia animal model
por: Hayashida, Maiko, et al.
Publicado: (2016)

Cognitive Behavioral Therapy for Insomnia as Adjunctive Therapy to Antipsychotics in Schizophrenia: A Case Report
por: Izuhara, Muneto, et al.
Publicado: (2018)

Remission of Psychosis in Treatment-Resistant Schizophrenia following Bone Marrow Transplantation: A Case Report
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2017)

PS147. Gunn rats show depression-like behavior and microglial activation in the hippocampus
por: Arauchi, Ryosuke, et al.
Publicado: (2016)

Aceruloplasminemia With Psychomotor Excitement and Neurological Sign Was Improved by Minocycline (Case Report)
por: Hayashida, Maiko, et al.
Publicado: (2016)

May Salivary Alpha-Amylase Level Be a Useful Tool for Assessment of the Severity of Schizophrenia and Evaluation of Therapy? A Case Report
por: Ieda, Masa, et al.
Publicado: (2012)

Parvalbumin-positive GABAergic interneurons deficit in the hippocampus in Gunn rats: A possible hyperbilirubinemia-induced animal model of schizophrenia
por: Hayashida, Maiko, et al.
Publicado: (2019)

PT596. The comparison with galantamine and donepezil on Alzheimer’s Disease patients and its relationship with cerebral blood flow
por: Wake, Rei, et al.
Publicado: (2016)

Implications of Systemic Inflammation and Periodontitis for Major Depression
por: Hashioka, Sadayuki, et al.
Publicado: (2018)

PM351. Efficacy and Safety of Sansoninto for Insomnia in Child and Adolescent Patients: An Open-Label Study
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2016)

The Possible Causal Link of Periodontitis to Neuropsychiatric Disorders: More Than Psychosocial Mechanisms
por: Hashioka, Sadayuki, et al.
Publicado: (2019)

Gunn rats with glial activation in the hippocampus show prolonged immobility time in the forced swimming test and tail suspension test
por: Arauchi, Ryosuke, et al.
Publicado: (2018)

Electroconvulsive therapy in catatonic patient infected with Sars-Cov-2
por: Bustamante, Jose, et al.
Publicado: (2021)

Treatment resistant non-catatonic mutism in schizophrenia responding to a combination of continuation electroconvulsive therapy and neuroleptics
por: Grover, Sandeep, et al.
Publicado: (2012)

Treatment of refractory catatonic schizophrenia with low dose aripiprazole
por: Sasaki, Tsuyoshi, et al.
Publicado: (2012)

Atypical Creutzfeldt-Jakob Disease Evolution after Electroconvulsive Therapy for Catatonic Depression
por: Grande, Iria, et al.
Publicado: (2011)

Unexpected cancellation on a catatonic patient’s electroconvulsive therapy due to the coronavirus pandemic
por: Casano, Kelsey, et al.
Publicado: (2020)

ECT induced mania in catatonic schizophrenia.
por: Agnihotri, Shruti, et al.
Publicado: (2022)

Wernicke encephalopathy complicating catatonic schizophrenia
por: Rihab, C., et al.
Publicado: (2021)

Psychosis in a primary hyperparathyroidism patient with mild hypercalcemia: A case report
por: Otsuki, Koji, et al.
Publicado: (2021)

Catatonic Schizophrenia: Cases with Possible Genetic Predisposition
por: Tariq, Maryam, et al.
Publicado: (2019)

Efficacy and Safety of Yokukansan in Treatment-Resistant Schizophrenia: A Randomized, Multicenter, Double-Blind, Placebo-Controlled Trial
por: Miyaoka, Tsuyoshi, et al.
Publicado: (2015)

Electroconvulsive Therapy in a Child Suffering from Acute and Transient Psychotic Disorder with Catatonic Features
por: Mohapatra, Satyakam, et al.
Publicado: (2015)

Salivary Alpha-Amylase Activity and Salivary Flow Rate in Young Adults
por: Arhakis, Aristidis, et al.
Publicado: (2013)

Yokukansan promotes hippocampal neurogenesis associated with the suppression of activated microglia in Gunn rat
por: Furuya, Motohide, et al.
Publicado: (2013)

Spontaneous Bladder Rupture in a Catatonic Schizophrenia Patient
por: Miyakoshi, Megumi, et al.
Publicado: (2023)

Salivary Alpha-Amylase Reactivity in Breast Cancer Survivors
por: Wan, Cynthia, et al.
Publicado: (2016)

Salivary Alpha-Amylase in Experimentally-Induced Muscle Pain
por: Christidis, Nikolaos, et al.
Publicado: (2020)

Clinical and demographic profile of catatonic patients who received electroconvulsive therapy in a South African setting
por: Odayar, Kavendren, et al.
Publicado: (2018)

Case Report: “Niemann-Pick Disease Type C in a Catatonic Patient Treated With Electroconvulsive Therapy”
por: van Verseveld, M., et al.
Publicado: (2021)

Electroconvulsive therapy as life-saving in an acute catatonic syndrome associated with bipolar disorder: A case report
por: Leite, R. Almeida, et al.
Publicado: (2021)

PM482. SALIVARY ALPHA-AMYLASE (sAA) AS A BIOMARKER FOR THE RESPONSE OF THERAPY IN SCHIZOPHRENIA PATIENTS
por: Liaury, Kristian, et al.
Publicado: (2016)

Salivary alpha amylase and salivary cortisol response to fluid consumption in exercising athletes
por: Backes, TP, et al.
Publicado: (2015)

A case of Hallervorden-Spatz disease presenting as catatonic schizophrenia
por: Pawar, Yogesh, et al.
Publicado: (2013)

Altered Salivary Alpha-Amylase Secretion in Patients with Ulcerative Colitis
por: Xu, Zhuoni, et al.
Publicado: (2018)

Salivary alpha-amylase as a stress biomarker in diseased dogs
por: Hong, Hwa-Ran, et al.
Publicado: (2019)

Salivary Alpha-Amylase as a Biomarker of Stress in Behavioral Medicine
por: Ali, Nida, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_aqm105k03acgklacoqeh4c0fkf